日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Schizosaccharomyces pombe Uncharacterized oxidoreductase C1739.08c (SPCC1739.08c) CSB-YP527928SXV
CSB-EP527928SXV
CSB-BP527928SXV
CSB-MP527928SXV
CSB-EP527928SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe ATP synthase subunit 5, mitochondrial (atp5) CSB-YP527929SXV
CSB-EP527929SXV
CSB-BP527929SXV
CSB-MP527929SXV
CSB-EP527929SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Mannose-1-phosphate guanyltransferase (mpg1) CSB-YP527930SXV
CSB-EP527930SXV
CSB-BP527930SXV
CSB-MP527930SXV
CSB-EP527930SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C285.05 (SPCC285.05) CSB-YP527931SXV
CSB-EP527931SXV
CSB-BP527931SXV
CSB-MP527931SXV
CSB-EP527931SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Upstream activation factor subunit spp27 (spp27) CSB-YP527932SXV
CSB-EP527932SXV
CSB-BP527932SXV
CSB-MP527932SXV
CSB-EP527932SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Set1 complex component spp1 (spp1) CSB-YP527933SXV
CSB-EP527933SXV
CSB-BP527933SXV
CSB-MP527933SXV
CSB-EP527933SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Histone chaperone cia1 (cia1) CSB-YP527934SXV
CSB-EP527934SXV
CSB-BP527934SXV
CSB-MP527934SXV
CSB-EP527934SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized N-acetyltransferase C663.13c (SPCC663.13c) CSB-YP527935SXV
CSB-EP527935SXV
CSB-BP527935SXV
CSB-MP527935SXV
CSB-EP527935SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized methyltransferase C70.08c (SPCC70.08c) CSB-YP527936SXV
CSB-EP527936SXV
CSB-BP527936SXV
CSB-MP527936SXV
CSB-EP527936SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Protein sly1 (sly1), partial CSB-YP527937SXV
CSB-EP527937SXV
CSB-BP527937SXV
CSB-MP527937SXV
CSB-EP527937SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized transcriptional regulatory protein C777.02 (SPCC777.02), partial CSB-YP527938SXV
CSB-EP527938SXV
CSB-BP527938SXV
CSB-MP527938SXV
CSB-EP527938SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Target of rapamycin complex 2 subunit bit61 (bit61) CSB-YP527939SXV
CSB-EP527939SXV
CSB-BP527939SXV
CSB-MP527939SXV
CSB-EP527939SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Branchpoint-bridging protein (bpb1), partial CSB-YP527940SXV
CSB-EP527940SXV
CSB-BP527940SXV
CSB-MP527940SXV
CSB-EP527940SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Rik1-associated factor 2 (raf2), partial CSB-YP527941SXV
CSB-EP527941SXV
CSB-BP527941SXV
CSB-MP527941SXV
CSB-EP527941SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida albicans Agglutinin-like protein 3 (ALS3), partial CSB-YP527942CZF
CSB-BP527942CZF
CSB-MP527942CZF
CSB-EP527942CZF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida albicans Methionine--tRNA ligase, mitochondrial (MSM1), partial CSB-YP527943CZF
CSB-EP527943CZF
CSB-BP527943CZF
CSB-MP527943CZF
CSB-EP527943CZF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Protein pob1 (pob1), partial CSB-YP527944SXV
CSB-EP527944SXV
CSB-BP527944SXV
CSB-MP527944SXV
CSB-EP527944SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Cell wall synthesis protein KRE9 (KRE9) CSB-YP527945CZI
CSB-EP527945CZI
CSB-BP527945CZI
CSB-MP527945CZI
CSB-EP527945CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia pastoris Pheromone-processing carboxypeptidase KEX1 (KEX1), partial CSB-YP527946EVS
CSB-EP527946EVS
CSB-BP527946EVS
CSB-MP527946EVS
CSB-EP527946EVS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida albicans Histidine biosynthesis trifunctional protein (HIS4), partial CSB-YP527947CZF
CSB-EP527947CZF
CSB-BP527947CZF
CSB-MP527947CZF
CSB-EP527947CZF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×